Literature DB >> 25775481

Correction: rapamycin ameliorates nephropathy despite elevating hyperglycemia in a polygenic mouse model of type 2 diabetes, NONcNZO10/LtJ.

.   

Abstract

Entities:  

Year:  2015        PMID: 25775481      PMCID: PMC4361708          DOI: 10.1371/journal.pone.0119748

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


× No keyword cloud information.
Information is missing from the Funding section. The correct funding information is as follows: This work was supported by the National Institutes of Health (AG022308, AG032333, AG038560 to DEH) (http://www.nia.nih.gov/), The Jackson Laboratory’s CA034196. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This paper is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
  1 in total

1.  Rapamycin ameliorates nephropathy despite elevating hyperglycemia in a polygenic mouse model of type 2 diabetes, NONcNZO10/LtJ.

Authors:  Peter C Reifsnyder; Rosalinda Doty; David E Harrison
Journal:  PLoS One       Date:  2014-12-04       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.